GB935384A
(en)
|
1959-03-30 |
1963-08-28 |
Pfizer & Co C |
Tetracycline derivatives and preparation thereof
|
US3338963A
(en)
|
1960-10-28 |
1967-08-29 |
American Cyanamid Co |
Tetracycline compounds
|
GB1034933A
(en)
|
1962-10-29 |
1966-07-06 |
American Cyanamid Co |
4-demethylamino-4-substituted amino 6-demethyl tetracyclines
|
US3364123A
(en)
|
1963-05-06 |
1968-01-16 |
Squibb & Sons Inc |
Production of 4n-demethyl-4n-ethyl tetracyclines
|
USRE26253E
(en)
|
1963-05-17 |
1967-08-15 |
|
And z-alkylamino-g-deoxytetracycline |
GB1065715A
(en)
|
1964-04-16 |
1967-04-19 |
Pfizer & Co C |
Tetracycline derivatives
|
US3247226A
(en)
|
1964-07-06 |
1966-04-19 |
American Cyanamid Co |
4-dimethylamino and 4-hydroxytetracycloxides
|
US3394178A
(en)
|
1965-01-26 |
1968-07-23 |
Merck & Co Inc |
Nu-ethyloxytetracycline
|
GB1077598A
(en)
|
1965-05-12 |
1967-08-02 |
Pfizer & Co C |
Preparation of n-demethyl tetracyclines
|
US3304227A
(en)
|
1965-07-15 |
1967-02-14 |
Loyal E Loveless |
Antibiotic-containing animal feed
|
US3433709A
(en)
|
1965-12-07 |
1969-03-18 |
American Cyanamid Co |
Biological transformation of alpha-6-deoxytetracyclines to tetracyclines
|
US3849493A
(en)
|
1966-08-01 |
1974-11-19 |
Pfizer |
D-ring substituted 6-deoxytetracyclines
|
US3824285A
(en)
|
1967-09-13 |
1974-07-16 |
Pfizer |
4-oxo-4-dedimethylaminotetracycline-4,6-hemiketals
|
US3947517A
(en)
|
1969-06-12 |
1976-03-30 |
Research Corporation |
Stereoselective introduction of tetracyclines hydroxyl group at 12(a) position in synthesis of tetracyclines
|
DE2437487A1
(de)
|
1974-08-03 |
1976-02-19 |
Merck Patent Gmbh |
7-methoxy-6-thia-tetracycline und verfahren zu ihrer herstellung
|
DE2442829A1
(de)
|
1974-09-06 |
1976-03-18 |
Merck Patent Gmbh |
Tetracyclische verbindungen und verfahren zu ihrer herstellung
|
YU290176A
(en)
|
1976-11-26 |
1982-05-31 |
Pliva Zagreb |
Process for preparing 4-dedimethylamino-4-arylsulfonamido-5a,6-anhydrotetracycline
|
US4925833A
(en)
|
1983-12-29 |
1990-05-15 |
The Research Foundation Of State University Of New York |
Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
|
US4666897A
(en)
|
1983-12-29 |
1987-05-19 |
Research Foundation Of State University |
Inhibition of mammalian collagenolytic enzymes by tetracyclines
|
USRE34656E
(en)
|
1983-12-29 |
1994-07-05 |
The Research Foundation Of State University Of New York |
Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
|
US4935412A
(en)
|
1983-12-29 |
1990-06-19 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
|
US4704383A
(en)
|
1983-12-29 |
1987-11-03 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
|
JP3016587B2
(ja)
|
1989-12-04 |
2000-03-06 |
ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク |
非ステロイド抗炎症剤及びテトラサイクリンの配合
|
US5308839A
(en)
|
1989-12-04 |
1994-05-03 |
The Research Foundation Of State University Of New York |
Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
|
US5770588A
(en)
|
1991-02-11 |
1998-06-23 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
|
US5231017A
(en)
|
1991-05-17 |
1993-07-27 |
Solvay Enzymes, Inc. |
Process for producing ethanol
|
US5494903A
(en)
|
1991-10-04 |
1996-02-27 |
American Cyanamid Company |
7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
|
DE69232302D1
(de)
|
1991-10-04 |
2002-01-31 |
American Cyanamid Co |
7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
|
USRE40183E1
(en)
|
1991-10-04 |
2008-03-25 |
Wyeth Holdings Corporation |
7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
|
US5258371A
(en)
|
1992-05-29 |
1993-11-02 |
Kuraray Co., Ltd. |
Method to reduce connective tissue destruction
|
US6043225A
(en)
|
1992-06-12 |
2000-03-28 |
Board Of Regents Of The University Of Washington |
Diagnosis and treatment of arterial chlamydial granuloma
|
US5442059A
(en)
|
1992-08-13 |
1995-08-15 |
American Cyanamid Company |
9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
|
US5284963A
(en)
|
1992-08-13 |
1994-02-08 |
American Cyanamid Company |
Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
|
SG47520A1
(en)
|
1992-08-13 |
1998-04-17 |
American Cyanamid Co |
New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
|
US5328902A
(en)
|
1992-08-13 |
1994-07-12 |
American Cyanamid Co. |
7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
|
US5420272A
(en)
|
1992-08-13 |
1995-05-30 |
American Cyanamid Company |
7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
|
JPH06256280A
(ja)
|
1992-11-17 |
1994-09-13 |
Univ New York State |
糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン
|
US6043231A
(en)
|
1993-03-02 |
2000-03-28 |
The Research Foundation Of State Univ. Of New York |
Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
|
US5523297A
(en)
|
1993-03-02 |
1996-06-04 |
The Research Foundation Of State University Of New York |
Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
|
US5371076A
(en)
|
1993-04-02 |
1994-12-06 |
American Cyanamid Company |
9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
|
US5668122A
(en)
|
1993-07-28 |
1997-09-16 |
Fife; Rose S. |
Method to treat cancer with tetracyclines
|
MX9603508A
(es)
|
1994-02-17 |
1997-03-29 |
Pfizer |
Analogos de la doxiciclina.
|
US5574026A
(en)
|
1994-12-13 |
1996-11-12 |
American Cyanamid Company |
Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
|
US5843925A
(en)
|
1994-12-13 |
1998-12-01 |
American Cyanamid Company |
Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
|
US5834449A
(en)
|
1996-06-13 |
1998-11-10 |
The Research Foundation Of State University Of New York |
Treatment of aortic and vascular aneurysms with tetracycline compounds
|
US5827840A
(en)
|
1996-08-01 |
1998-10-27 |
The Research Foundation Of State University Of New York |
Promotion of wound healing by chemically-modified tetracyclines
|
US5789395A
(en)
|
1996-08-30 |
1998-08-04 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
US5919774A
(en)
|
1996-12-10 |
1999-07-06 |
Eli Lilly And Company |
Pyrroles as sPLA2 inhibitors
|
US5837696A
(en)
|
1997-01-15 |
1998-11-17 |
The Research Foundation Of State University Of New York |
Method of inhibiting cancer growth
|
US5773430A
(en)
|
1997-03-13 |
1998-06-30 |
Research Foundation Of State University Of New York |
Serine proteinase inhibitory activity by hydrophobic tetracycline
|
US5929055A
(en)
|
1997-06-23 |
1999-07-27 |
The Research Foundation Of State University Of New York |
Therapeutic method for management of diabetes mellitus
|
WO1999037307A1
(fr)
|
1998-01-23 |
1999-07-29 |
Trustees Of Tufts College |
Composes actifs du point de vue pharmaceutique et leurs methodes d'utilisation
|
US6277061B1
(en)
|
1998-03-31 |
2001-08-21 |
The Research Foundation Of State University Of New York |
Method of inhibiting membrane-type matrix metalloproteinase
|
US6015804A
(en)
|
1998-09-11 |
2000-01-18 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds to enhance interleukin-10 production
|
US5977091A
(en)
|
1998-09-21 |
1999-11-02 |
The Research Foundation Of State University Of New York |
Method of preventing acute lung injury
|
JP2002525299A
(ja)
|
1998-09-28 |
2002-08-13 |
ザ リサーチ ファウンデーション オブ ステイト ユニヴァーシティ オブ ニューヨーク |
新規白内障形成抑制剤
|
US5998390A
(en)
|
1998-09-28 |
1999-12-07 |
The Research Foundation Of State University Of New York |
Combination of bisphosphonate and tetracycline
|
US6914057B1
(en)
|
1998-09-28 |
2005-07-05 |
The Research Foundation Of State University Of New York |
Inhibitor of cataract formation
|
US6231894B1
(en)
|
1999-10-21 |
2001-05-15 |
Duke University |
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
|
WO2001098260A1
(fr)
|
2000-06-16 |
2001-12-27 |
Trustees Of Tufts College |
Composes de phenyl tetracycline 7-n-substituee
|
EP1301467B1
(fr)
|
2000-07-07 |
2006-08-16 |
Trustees Of Tufts College |
Composes de monocycline 9-substitues
|
KR100619637B1
(ko)
|
2000-07-07 |
2006-09-12 |
트러스티즈 오브 터프츠 칼리지 |
7-치환 테트라사이클린 화합물
|
EP1303479B1
(fr)
|
2000-07-07 |
2011-04-06 |
Trustees Of Tufts College |
Composes de tetracycline substitues en 7, 8 et 9
|
EP2301914A1
(fr)
|
2001-03-13 |
2011-03-30 |
Paratek Pharmaceuticals, Inc. |
Composés de tétracycline substitués en position 7, 9
|
EP1379255A2
(fr)
|
2001-03-14 |
2004-01-14 |
Paratek Pharmaceuticals, Inc. |
Composes de tetracycline substitues, en tant qu'agents antifongiques
|
WO2002072031A2
(fr)
|
2001-03-14 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
Composes de tetracycline substitue utilises en tant qu'antifongiques synergiques
|
WO2002085303A2
(fr)
|
2001-04-24 |
2002-10-31 |
Paratek Pharmaceuticals, Inc. |
Composes de tetracycline substitues destines au traitement de la malaria
|
US8088820B2
(en)
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
US20060194773A1
(en)
|
2001-07-13 |
2006-08-31 |
Paratek Pharmaceuticals, Inc. |
Tetracyline compounds having target therapeutic activities
|
JP2004537544A
(ja)
|
2001-07-13 |
2004-12-16 |
パラテック ファーマシューティカルズ インコーポレイテッド |
標的治療活性を有するテトラサイクリン化合物
|
US7056902B2
(en)
|
2002-01-08 |
2006-06-06 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
EA013819B1
(ru)
|
2002-03-08 |
2010-08-30 |
Паратек Фармасьютикалс, Инк. |
Аминометилзамещенные тетрациклиновые соединения
|
EA200401232A1
(ru)
|
2002-03-21 |
2005-12-29 |
Пэрэтек Фамэсьютикэлс, Инк. |
Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
|
EP1534300A4
(fr)
|
2002-07-12 |
2008-04-23 |
Paratek Pharm Innc |
Composes de tetracycline substituee en 3, 10, et 12a
|
JP4686189B2
(ja)
|
2002-10-24 |
2011-05-18 |
パラテック ファーマシューティカルズ インコーポレイテッド |
Rnaを調節するための置換テトラサイクリン化合物の使用方法
|
JP2006503898A
(ja)
|
2002-10-24 |
2006-02-02 |
パラテック ファーマシューティカルズ, インク. |
マラリア治療のための置換テトラサイクリン化合物
|
EA200600221A1
(ru)
|
2003-07-09 |
2006-06-30 |
Пэрэтек Фамэсьютикэлс, Инк. |
Замещённые соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
|
WO2005082860A1
(fr)
|
2004-02-27 |
2005-09-09 |
National Research Council Of Canada |
Tetracyclines et leur utilisation en tant qu'inhibiteurs de la calpaine
|
JP2007535565A
(ja)
|
2004-04-30 |
2007-12-06 |
バイエル ファーマシューティカルス コーポレーション |
癌の治療に有用な置換ピラゾリル尿素誘導体
|
PL1753713T3
(pl)
|
2004-05-21 |
2017-02-28 |
President And Fellows Of Harvard College |
Synteza tetracyklin oraz ich analogów
|
EP2284150A3
(fr)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Composés de tétracycline substituée
|
EP2301916A3
(fr)
|
2004-10-25 |
2011-09-28 |
Paratek Pharmaceuticals, Inc. |
4-aminotétracyclines et procédés d'utilisation associés
|
CA2597212A1
(fr)
|
2005-02-04 |
2006-08-10 |
Paratek Pharmaceuticals, Inc. |
Derives 11a, 12 de composes de tetracycline
|
EP1848686A2
(fr)
|
2005-02-15 |
2007-10-31 |
Wyeth |
Tetracyclines 9-substituees
|
JP2009502809A
(ja)
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
10−置換テトラサイクリンおよびその使用方法
|
WO2007087416A2
(fr)
|
2006-01-24 |
2007-08-02 |
Paratek Pharaceuticals, Inc. |
Procede permettant d'accroitre la biodisponibilite orale de tetracyclines
|
US8486921B2
(en)
|
2006-04-07 |
2013-07-16 |
President And Fellows Of Harvard College |
Synthesis of tetracyclines and analogues thereof
|
EP2029749A2
(fr)
|
2006-05-15 |
2009-03-04 |
Paratek Pharmaceuticals, Inc. |
Méthodes de régulation de l'expression de gènes ou de produits géniques à l'aide de composés de tétracycline substituée
|
EP3056487B1
(fr)
|
2006-10-11 |
2018-02-21 |
President and Fellows of Harvard College |
Synthèse d'un intermédiaire de l'énone
|
WO2008045507A2
(fr)
|
2006-10-11 |
2008-04-17 |
Paratek Pharmaceuticals, Inc. |
Composés de tétracycline substitués utilisés pour le traitement d'infections à bacillus anthracis
|
PL2109602T3
(pl)
|
2006-12-21 |
2014-09-30 |
Paratek Pharm Innc |
Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych
|
AU2008239606A1
(en)
|
2007-04-12 |
2008-10-23 |
Paratek Pharmaceuticals, Inc. |
Methods for treating spinal muscular atrophy using tetracycline compounds
|
EA201070233A1
(ru)
|
2007-07-06 |
2010-08-30 |
Паратек Фармасьютикалс, Инк. |
Способы синтеза замещённых соединений тетрациклина (варианты)
|
WO2009073056A1
(fr)
|
2007-09-07 |
2009-06-11 |
Dr. Reddy's Laboratories Ltd. |
Nouveaux dérivés de tétracycline utiles en tant qu'agents antibactériens
|
WO2009128913A1
(fr)
|
2008-04-14 |
2009-10-22 |
Paratek Pharmaceuticals, Inc. |
Composés à base de tétracyclines substituées
|
EP2307027A4
(fr)
|
2008-07-11 |
2012-08-15 |
Neumedics |
Dérivés de tétracycline présentant une activité antibiotique réduite et des bénéfices neuroprotecteurs
|
HUE026562T2
(hu)
|
2008-08-08 |
2016-06-28 |
Tetraphase Pharmaceuticals Inc |
C7-fluor-helyettesített tetraciklin vegyületek
|
WO2010126607A2
(fr)
|
2009-04-30 |
2010-11-04 |
President And Fellows Of Harvard College |
Synthèse de tétracyclines et intermédiaires de celles-ci
|
WO2010129055A1
(fr)
|
2009-05-08 |
2010-11-11 |
Tetraphase Pharmaceuticals, Inc. |
Composés de 8-aza tétracycline
|
US9315451B2
(en)
|
2009-05-08 |
2016-04-19 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
US20120115819A1
(en)
|
2009-05-13 |
2012-05-10 |
Clark Roger B |
Pentacycline Compounds
|
DK2470500T3
(en)
|
2009-08-28 |
2018-01-08 |
Tetraphase Pharmaceuticals Inc |
tetracycline
|
JP2013521314A
(ja)
|
2010-03-10 |
2013-06-10 |
ユニバーシティー ヘルス ネットワーク |
癌の処置のためのチゲサイクリンの使用
|
MX2012011453A
(es)
|
2010-03-31 |
2013-02-15 |
Tetraphase Pharmaceuticals Inc |
Compuestos de tetraciclina policíclica.
|
TW201245116A
(en)
|
2010-08-12 |
2012-11-16 |
Tetraphase Pharmaceuticals Inc |
Tetracycline analogs
|
WO2012047907A1
(fr)
|
2010-10-04 |
2012-04-12 |
President And Fellows Of Harvard College |
Synthèse de tétracyclines substituées en c5, leurs utilisations, et intermédiaires dans la synthèse de celles-ci
|
DK2707003T3
(da)
*
|
2011-05-12 |
2019-08-05 |
Paratek Pharm Innc |
Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf
|
ES2712476T3
(es)
|
2012-08-31 |
2019-05-13 |
Tetraphase Pharmaceuticals Inc |
Compuestos de tetraciclina
|
MA40836A
(fr)
*
|
2014-10-23 |
2017-08-29 |
Tetraphase Pharmaceuticals Inc |
Procédures de semi-synthèse
|
WO2017097891A1
(fr)
*
|
2015-12-10 |
2017-06-15 |
Sandoz Ag |
Éravacycline cristalline
|
EP3390358B1
(fr)
|
2016-01-22 |
2020-09-23 |
Sandoz AG |
Bis-hydrochlorure cristalin d'eravacycline
|
KR102558540B1
(ko)
|
2016-08-30 |
2023-07-21 |
테트라페이즈 파마슈티컬스, 인코포레이티드 |
테트라사이클린 화합물 및 치료 방법
|
SI3529236T1
(sl)
*
|
2016-10-19 |
2024-08-30 |
Tetraphase Pharmaceuticals, Inc. |
Kristalinične oblike eravaciklina
|